chrisvoncsefalvay/vaers-outcomes huggingface dataset:
heaviness in chest with right flank pain; lots of phlegm; Pulse oximeter 89%; difficulty breathing heaviness in chest/Shortness of breath; difficulty breathing heaviness in chest/ heaviness in chest with right flank pain; Chills; Sensitive skin; Super Thirsty; Fever 100.7/Low grade fever 99.9/ Low grade fever 99.0; Joint Pain; Congestion; Right arm injection site severe pain; This is a spontaneous report from a contactable other healthcare professional (Patient). A 63-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL1284), via an unspecified route of administration on 06Jan2021 10:30 at single dose in Right arm for COVID-19 immunization.  Medical history included hypertension. Concomitant medication included benazepril hydrochloride, hydrochlorothiazide (BENAZEPRIL/HCTZ, 10-12.5 MG Tablet), ascorbic acid, biotin, boron, calcium, calcium pantothenate, chlorine, chromium, colecalciferol, copper, cyanocobalamin, folic acid, iodine, magnesium, manganese, molybdenum, nickel, nicotinamide, phosphorus, phytomenadione, potassium, pyridoxine hydrochloride, retinol, riboflavin, selenium, silicon dioxide, thiamine hydrochloride, tocopherol, vanadium, zinc (CENTRUM SILVER).  The patient previously took codeine and experienced allergy. There were no other vaccines received in four weeks. The patient did not have covid-19 prior vaccination. The patient did not have covid-19 tested post vaccination. On 06Jan2021 20:00, the patient experienced Fever 100.7, Joint Pain, Congestion, Right arm injection site severe pain. On 07Jan2021, the patient experienced Chills, Fever 100.7, Sensitive skin, Super Thirsty. On 08Jan2021, the patient had Temperature 98.8, No Chills, Thirsty. On 09Jan2021, the patient was Some relief, no fever, no chills, no joint pain. On 10Jan2021, the patient experienced low grade fever 99.9, Pulse oximeter 89%, difficulty breathing heaviness in chest. On 11Jan2021, oxygen was 92%, Low grade fever 99.0. On 12Jan2021, vital signs stable no fever 97.7, oxygen 96%. On 13Jan2021, Vital Signs stable. On 14Jan2021, the patient experienced Shortness of breath, heaviness in chest with right flank pain, lots of phlegm, Temperature 98.0, Oximeter 96%. Coricidin HBP taken to relieve Congestion. Therapeutic measures were taken as a result of all reported events. The outcome of event chills was recovered on 08Jan2021, outcome of event Fever (event onset date: 06Jan2021 20:00) was recovered on 09Jan2021, outcome of event Low grade fever (event onset date: 10Jan2021) was recovered on 12Jan2021, outcome of event Joint Pain was recovered in Jan2021. The outcome of the other events was recovering.
Day after vaccine I had a mild rash around the vaccination site, not bigger than the bandaid. Not much heat and only a little itchy. Honestly I chalked it up to the bandaid irritating my skin.  The next morning I woke up to swollen lips, hives all over my body, and super itchy. Honestly, it looked/felt like I had been out in the intense sun with burns/hives/sunburnt lips.
Several days after vaccination pt began having swelling and redness to face.  Over next week symptoms worsen to extreme swelling and redness of face, redness to neck, itchiness of legs.  Pt used steroid cream with some relief.  Symptoms took approximately three weeks to resolve.  This was pt's 6th covid vaccine.
Body chills, high fever, body aches, nausea, vomiting, headache.
About 56 hours after vaccination, pt developed hives over about 70% of her body. No other effects other than a sore arm.
>35 days from first dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (>35 days from first dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022B21A and 012A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (>35 days from first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (>35 days from first dose) outcome was unknown.            Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 03-Mar-2022: Follow-up received contains no new information
Twitching under left eye and in their left cheek; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TWITCHING (Twitching under left eye and in their left cheek) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced MUSCLE TWITCHING (Twitching under left eye and in their left cheek). At the time of the report, MUSCLE TWITCHING (Twitching under left eye and in their left cheek) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No concomitant medications were reported.  Treatment for the events were not reported.
Wrong Vaccine Administered; Extra dose administered; This non-serious case was reported by a physician via call center representative and described the occurrence of wrong vaccine administered in a 16-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA732A, expiry date 31-MAR-2024) for prophylaxis.   Concomitant products included MENVEO.   On 13-JUL-2023, the patient received the 3rd dose of Menveo (intramuscular) .5 ml. On 13-JUL-2023, an unknown time after receiving Menveo and an unknown time after receiving MENVEO, the patient experienced wrong vaccine administered (Verbatim: Wrong Vaccine Administered) and extra dose administered (Verbatim: Extra dose administered ). The outcome of the wrong vaccine administered and extra dose administered were unknown.   Additional Information: GSK receipt date 13 Jul 2023 The patient was administered a Menveo vaccine on the day of reporting, instead of a Bexsero. The patient received her second Menveo vaccine one month ago and received a third Menveo vaccine on the day of reporting. The patient was supposed to receive a Bexsero vaccine (Wrong Vaccine Administered). The reporter consented to follow up. The patient received 3rd dose of menveo vaccine instead of Bexsero vaccine which led to wrong Vaccine administered and extra dose administered.
Information has been received from a nurse concerning her 15 year old daughter with no pertinent medical history, drug reactions/allergies or concomitant medication usage, who in December 2008 (exact date not reported), was vaccinated (site and route not reported) with the 1st dose of GARDASIL (lot# not reported). In January 2007 (exact date not reported), the patient experienced irregular menstrual period. In June 2007 (exact date not reported), the patient was vaccinated (site and route not reported) with the 2nd dose of GARDASIL (lot# not reported), the patient has not received her third dose of GARDASIL. The patient did receive unspecified medical attention and at the time of this report had not recovered. Additional information has been requested. 2/12/2010 follow up- menstruation irregular: inappropriate schedule of drug administration  information has been received from a nurse concerning her 15 year old daughter with no pertinent medical history, drug reactions/allergies or concomitant medication usage, who in december 2006(exact date not reported) was vaccination site and route was not reported. with the 1st dose of HPV 6 11 16 VLF vaccine [yeast] [lot# not reported]- in january 2007 (exact date not reported). the patient experienced irregular menstrual period. in june 2007 (exact date reported) with the 2nd dose of HPV 6 11 16 18 VLP(lot# vaccine not reported). the patient has not received her third dose of the HPV 6 11 16 18 VLF vaccine. the patient did receive unspecified medical attention and at the time of this report. the patient had not recovered.
I have Tinnitus. All tests have been performed and I have been "living with it" for almost 20 years. After my secon shot it's been getting increasingly louder. I have been waking up in the night due to the intensity. I did not consult my doctor because I thought it was part of my usual Tinnitus which they always say cannot be cured.
Case number PHEH2011US02101 is an initial spontaneous report received from health care professional on 17 Aug 2011. this report refers to an 18 year old male patient. He was vaccinated with MENVEO (batch number: M10051) intramuscularly on 13 Aug 2011. But, he received only the Men CWY liquid conjugate without reconstituting it with the Men A lyophilized powder component. No adverse reaction had occurred following this drug administration error.
Information has been received from a pharmacist referring to a 65 year old male patient with asthma (developed on an unspecified date prior to receive PNEUMOVAX 23) and no drug reactions/ allergies. On 23-OCT-2014 the patient was vaccinated with a dose of PNEUMOVAX 23 lot # K009106, expiration date: 25-FEB-2016, 0.5 ml, intramuscularly. On the same day the patient received a dose of FLUCELVAX (manufacturer unspecified). Other concomitant therapies included valsartan, CELEBREX, ZETIA, albuterol and atorvastatin. On approximately 24-OCt-2014, within 24-48 hours of receiving PNEUMOVAX 23 the patient developed swelling at the injection site as well as a fever and chills. On 27-OCT-2014 the patient saw his physician for medical attention and BACTRIM was prescribed by the physician to treat the adverse events. The outcome of the adverse events was unknown. The relationship of the adverse events and PNEUMOVAX 23 was not reported. This is one of several reports (MARRS#1502USA010690; MARRS#1502USA010624) received from the same reporter. Additional information has been requested.
Patient experienced chest pain and headache with 6+ month COVID vaccine booster. Patient was taken to ED.
Pt had a 14 hr cry spell - OTC TYLENOL not helpful. No fever or other - inconsolable cry x 14 hrs.
About an hour after getting the second dose I started to need to urinate every hour and a half. the next morning it was the same but I couldn't urinate. I went to urgent care at around 12 and they diagnosed me with Acute Cystitis with Hematuria (a UTI). I have never had a UTI before, I'm not sexually active nor ever have been, and I know how to clean properly.  urgent care prescribed me Cephalexin and Pyridium.
Patient complained of 4 inch diameter of redness, edema encircling entire upper arm and it includes axilla, weakness, and states, "couldn't move arm for 2 days." Patient currently taking Ibuprofen and is seeing some slight daily improvements.
Patient complained of  having a rapid heart beat , cold and  clamy hands and  vaccination area was purple in color and hot to the touch. Patient was seen by EMT on site where her blood pressure and pluse rate was monitored.  (1) 144/88 , (2) 128/90 , (3) 128/92 . Pulse Rate (1) 103 , (2) 100 , (3) 111.   Patient  did not have to be transferred to a medical facility and was cleared to return home by EMT .
23 y.o. male who arrived by to the emergency department for suspected allergic reaction.  Patient received his Covid vaccine 3 hours prior to ED arrival.  Initially he was asymptomatic however, as the morning progressed, he developed a redness around the injection site.  He then noticed a rash all over his face, that was mildly itchy in nature and felt warm.  He denies any associated wheezing, shortness of breath, facial swelling, throat swelling, severe abdominal pain, vomiting, lightheadedness, dizziness, or syncope.  He has not taken anything for his symptoms, and they continue to worsen.  He has no prior history of allergic reaction to vaccines or other known allergies in the past.   He states this is mildly itchy in nature.  Patient was given 50 mg of p.o. Benadryl and Pepcid for symptomatic control.  He was observed in the ED for 2 hours without any progression of his symptoms, no associated facial swelling, wheezing, shortness of breath, abdominal pain, vomiting, or hypotension to suggest anaphylactic reaction.  He was discharged home in stable condition
appendicitis; intense abdominal pain; This is a spontaneous report from a contactable consumer (patient). A 76-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in the left arm on 06Feb2021 15:45 (03:45 PM) at a single dose as Covid vaccine. Medical history included gastrointestinal distress at the time of incident. The patient had no known allergies. Concomitant medications included cyanocobalamin (B12), calcium, levothyroxine sodium (LEVOXYL), lisinopril, and ergocalciferol (VIT D). The patient developed intense abdominal pain on 08Feb2021 10:00 AM. She went to the ER on 09Feb2021 and a CT scan on 09Feb2021 which revealed that she had appendicitis on 08Feb2021 10:00 AM. The patient was hospitalized for the events from 09Feb2021 to 13Feb2021 (4 days of hospitalization). Treatment for the events included intravenous antibiotics. The patient had no Covid prior to vaccination. Additional lab data included Covid test type post vaccination Nasal Swab with negative result on 09Feb2021 (Covid tested post vaccination). The outcome of the events was recovering.  Information on the lot/batch number has been requested.
Expired vaccine used; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 08-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was provided by the reporter. No treatment medication was provided.
Pt reported Respiratory distress, flushing/sweating and light headedness. Vitals: 92/60, 53, 21, SpO2 100% on RA -- > @14:00 97/58. Pt given water and juice.  Pt also given ice pack.  Pt stable and released from the vaccination site.
Left deltoid with complex regional pain syndrome. Reports shooting pain proximally and distally to the fingers.
He got his vaccine, about 12-24 hours after the vaccine he started getting small raised bumps on his hands and arms.  Over the course of the next few days they multiplied all over his body and some areas has raised skin more like  hives.  If you scratch them they itch, and if you scratch them they bleed.  He spoke to the nurse at work this morning, who recommended some Benadryl and Hydrocortisone cream.  He has been taking hot showers and soap up until now, has not treated it with anything yet.  He got his vaccine from the nurse at work.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. On 10-SEP-2013, the patient were vaccinated with a dose of ZOSTAVAX (lot# J001694, expiration date 08-MAY-2014, dose, frequency, route and indication not reported). The vaccine was stored improperly at temperatures up to 21F from 01-JUL-2013 to 08-OCT-2013. On 08-OCT-2013, the vaccine was discarded. No adverse effects were reported. It was unspecified if the patient had sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
One 10/18/2021, patient received his first dose of COVID vaccine, it was a Pfizer vaccination. On 11/08/2021, when the patient returned for his booster, he was inadvertently given 0.5 mL of Moderna vaccination. I contacted both manufacturer's and was told that as long as both vaccines are mRna, the patient is considered fully vaccinated after weeks.
harden lump tender about 1 &1/2 inches in diameter. also was bumped at a meeting and hurt
pt recv vax 28MAY96 & 2JUN96 pt exp ataxia;mom reported pt appeared drunk & balance was off;pt taken to ER;diffuse macular rash was noted on pt face & around eyes w/1-2mm non-focal spots on trunk & back of neck;rash was allerg w/unk origin;
Report #2000026283-1 describes hepatitis B core positive in a 61 year old pt who rec'd Engerix-B. The pt's allergies are not specified. Her medical history includes hepatitis C, hypothyroidism, and diskectomy and fusion. she takes levothyroxine sodium (Synthoid) and an omega series interferon (Isis) as an experimental treatment for hepatitis C. On unspecified dates, the pt rec'd  her first, second,and third doses of Engerix-B, respectively. 31 days after receiving dose 3 of Engerix-B, she was found to have hepatitis B core positive. As of 8/28/00, the outcome of the event is ongoing.
9 hours after receiving routine 2 month immunizations (DTaP, Hib, rotavirus, inactivated polio) this pt became first drowsy then lethargic and pale. Pt was brought to ER were he had episodes of bradycardia with desaturations. Events continued hourly for 24 hours and lethargy slowly finished over the next 48 hours.
feeling cold; felt very uncomfortable; go to bed where he was shaking; Initial information received on 17-Sep-2023 regarding an unsolicited valid  non-serious case received from a consumer/non-healthcare professional.  This case involves a 82 years old male patient who experienced go to bed where he was shaking, feeling cold and felt very uncomfortable after receiving vaccine influenza quadrival A-B high dose HV vaccine [Fluzone High-Dose Quadrivalent].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 11-Sep-2023, the patient received a dose of suspect influenza quadrival A-B high dose HV vaccine Suspension for injection in pre-filled syringe lot NDC 49281-0123-65 via intramuscular route in unknown administration site for prophylactic vaccination (immunization).  On 11-SEP-2023 the patient developed go to bed where he was shaking (chills), feeling cold and felt very uncomfortable (discomfort) on the same day following the administration of influenza quadrival A-B high dose HV vaccine.  Reportedly, Following a Fluzone High Dose injection on Sep 11th, 2023, the patient felt very uncomfortable, was cold and had to go to bed where he was shaking due to feeling cold. Symptoms disappeared the next day after one night in bed.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the events go to bed where he was shaking, feeling cold, felt very uncomfortable.  At time of reporting, the outcome was Recovered / Resolved on 12-Sep-2023 for the event go to bed where he was shaking, feeling cold and felt very uncomfortable.
Polyarthralgia, responds to ibuprofen, symptoms improving with time but still present 6 days after vaccine
The patient was given Janssen vaccine @ 11:38am. She stated she had anaphylaxis reaction before after colonoscopy was not sure exactly what from. Made sure this vaccine didn't have PEG in it. Asked her to stay for 30 minutes after vaccine so I could monitor her. Around 12:10pm she said her mouth felt like anaphylaxis may happen. Asked her if she felt like she could swallow she said yes gave her (2) 25mg diphenhydramine. Had her sit and took her blood pressure which was BP 202/101 hr 70 I asked her if maybe she was anxious she said no she was very calm. Around 12:20pm she said felt throat was closing like before told partner to call 911. Got out Epi pen 0.3mg but she had her own administered 1 dose in right thigh. Shortly after EMS arrived and took over. The whole time she was awake and alert and responsive. Spoke to her around 4pm she was just leaving ER and said she was doing better.
This spontaneous report was received from a registered nurse refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. In approximately 2016 (since 08-FEB-2016), the patients were vaccinated with improperly stored doses of M-M-R II lot # L020189, expiration date 03-JUN-2016; lot # L026551, expiration date 16-JUL-2017 (dose and route of administration were not reported). There was no adverse effect reported. Administered doses of vaccine experienced the temperature excursion of 9 degrees Celsius for 9 hours. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Follow up has been received on 14-SEP-2016, reporting the administered vaccine doses that have experienced multiple temperature excursions. It was reported that the patients were vaccinated with M-M-R II (lot # L030162, expiration date: 11-AUG-2016) on 27-MAY-2016, 28-MAY-2016, 06-JUN-2016, 08-JUN-2016, 09-JUN-2016, 14-JUN-2016, 16-JUN-2016, 20-JUN-2016, 22-JUN-2016, 30-JUN-2016, 07-JUL-2016, 09-JUL-2016, 13-JUL-2016 and 14-JUL-2016. The longest duration of temperature excursion with M-M-R II was 18 hours and the range of the temperature excursion was between 30 and 34.5 Fahrenheit degrees. The temperature excursions were detected by a data logger. Additional information has been requested. General, product, event information and narrative were updated.
Information has been received from a Licensed Visiting Nurse concerning a 12 year old patient who on 03-APR-2009 was vaccinated with the first dose of GARDASIL. The patient was vaccinated with a second dose of GARDASIL on 06-JUN-2008 and the third dose was given on 06-AUG-2008. No adverse reactions were reported. Additional information has been requested.
Had swelling, redness (8cm X 7 1/2cm) to left upper arm, warm to the touch and also had a fever of 99.9F. Seen at PCP office on 9/27/00 and prescribed Duricef for 7 days treatment.
patient fainted approximately 10 minutes after administration and regained consciousness almost immediately and did not report any other adverse effects
Period has been messed up since vaccine. It comes 2-3 weeks late at times, and others it comes 2 weeks after the previous period. I have had several days of spotting between periods. As well as abdominal cramps and bloating.
8/3/21 Admitted to hospital. Breakthrough COVID :   PMH of CVA and is noncommunicative, from a skilled nursing facility.  She was noted to be moaning and grunting more than usual and was noted to be hypoxic and sent to the WP ER.  COVID-19 +.  CRP is 266.4.  Lactic acid is 1.2.  Chest x-ray shows diffuse pulmonary infiltrates compatible with pneumonia.  She is started on remdesivir and dexamethasone.  She has PEG tube in place.  Her temperature was 102.6 yesterday. Patient received Pfizer COVID-19 vaccine, last dose January 2021. 8/12/2021: Patient discharged to SNF
15MAR93 pt began to exp shooting pains down rt arm beginning @ the inject site & cont down to the wrist area; unable to move arm; four small blister appeared approx 2" above the inject site; shingles;
After vaccine, had severe joint and muscle aches, chills, headaches, lasted about 24 hours, then had extreme fatigue, nauseauh, 99.6 fever (usually 97).skipped work. Took advil